Skip to main content
Newsroom
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
Read more
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
Read more
Video review of the first results of the yellow fever study
First results of yellow fever study published in the Lancet
Read more
Yellow fever study : expansion of patient categories
Read more
MSF Foundation Supports Epicentre in New Yellow Fever Study
Read more
